A5005904384- Eosinophilic Esophagitis
- Helicobacter pylori-related gastroenterology studies
- Celiac Disease Research and Management
- Inflammatory Bowel Disease
- Microscopic Colitis
- Gastrointestinal disorders and treatments
- COVID-19 Clinical Research Studies
- COVID-19 and healthcare impacts
- Gastroesophageal reflux and treatments
- Gastric Cancer Management and Outcomes
- Eosinophilic Disorders and Syndromes
- Diverticular Disease and Complications
- Gastrointestinal Tumor Research and Treatment
- Health Systems, Economic Evaluations, Quality of Life
- SARS-CoV-2 and COVID-19 Research
- Chronic Disease Management Strategies
- Biosimilars and Bioanalytical Methods
- Long-Term Effects of COVID-19
- Frailty in Older Adults
- Immunodeficiency and Autoimmune Disorders
- Genetic factors in colorectal cancer
- IL-33, ST2, and ILC Pathways
- Pancreatitis Pathology and Treatment
- Cancer Immunotherapy and Biomarkers
- Pharmaceutical studies and practices
University of Pavia
2016-2025
Istituti di Ricovero e Cura a Carattere Scientifico
2014-2025
Policlinico San Matteo Fondazione
2011-2025
University Hospital Foundation
2017-2025
Leeds Teaching Hospitals NHS Trust
2017-2022
Aziende Socio Sanitaria Territoriale Rhodense
2022
GTx (United States)
2021
Pennine Care NHS Foundation Trust
2021
University College London
2021
The Royal Free Hospital
2021
COVID-19 has rapidly become a major health emergency worldwide. Patients with IBD are at increased risk of infection, especially when they have active disease and taking immunosuppressive therapy. The characteristics outcomes in patients remain unclear.This Italian prospective observational cohort study enrolled consecutive an established diagnosis confirmed COVID-19. Data regarding age, sex, (type, treatments clinical activity), other comorbidities (Charlson Comorbidity Index (CCI)), signs...
Inflammatory bowel disease [IBD] patients are still under-diagnosed or diagnosed with serious delay. We examined whether diagnostic delay [DD] in IBD has changed over the last 60 years, and explored risk factors of longer DD. In total, 3392 recorded registry four Italian centres were divided according to year diagnosis into a historical cohort [HC: 1955–84] modern [MC: 1985–2014]. DD, i.e. time lapse between onset symptoms indicative definitive diagnosis, was sub-periods [0–6, 7–12, 13–24,...
Summary Background Autoimmune atrophic gastritis (AAG) is characterised by a wide clinical spectrum that could delay its diagnosis. Aims To quantify the diagnostic in patients suffering from AAG and to explore possible risk factors for longer delay. Methods Consecutive with evaluated at our gastroenterological outpatient clinic between 2009 2018 were included. Diagnostic was estimated as time lapse occurring appearance of first likely symptoms, laboratory alterations, other clues indicative...
Summary Background Autoimmune atrophic gastritis (AAG) is an immune‐mediated disorder characterised by destruction of gastric oxyntic mucosa Aim To explore histopathological evolution in a cohort AAG patients over prolonged follow‐up Methods Single centre prospective study enrolling consecutive with histologically confirmed between 2000 and 2018. All undergoing endoscopic every 1‐3 years were classified as having stages 1, 2 or 3 according to atrophy severity (mild, moderate severe). either...
The extent and factors associated with risk of diagnostic delay in pediatric celiac disease (CD) are poorly understood.